MedPath

Multiprofessional Program for Obesity Treatment in adolescents

Not Applicable
Recruiting
Conditions
Obesity, Metabolic Syndrome
C18.654.726.500
C18.452.394.968.500.570
Registration Number
RBR-45ywtg
Lead Sponsor
niversidade Estadual de Maringá
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Adolescents classified as overweight or obese according to the criteria established by Cole et. al (2000); concordance of the adolescent and his/her parents/guardians in participating integrally in the interventions.

Exclusion Criteria

The exclusion criteria will be: endocrine and metabolic diseases previously diagnosed and informed to the pediatrician; long-term alcohol consumption; use of glucocorticoids and psychotropics which could affect appetite regulation; less than 70 % compliance in all multidisciplinary interventions.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reducing body fat verified by bioelectrical impedance analysis device based on statistically significant difference (p <0.05), comparing the measures of the week before the beginning of the interventions and the one obtained on the next week after the completion of 16 and/or 32 weeks of intervention.
Secondary Outcome Measures
NameTimeMethod
Increase the level of cardiorespiratory fitness verified by the 20 meters Leger test based on statistical difference (p <0.05), among the results obtained on the week before the beginning of the interventions and those ones verified in the next week after the end of 16 and 32 weeks intervention.;Improvements in the quality of life related to health checked by the generic questionnaire PedsQLTM 4.0 based on statistically significant difference (p <0.05), among the evaluations being held on the week before the beginning of the interventions and on the next week after the end of 16 and 32 weeks intervention.;Reduction in the prevalence of metabolic syndrome (MS) based on the cutoff points from the International Diabetes Federation (IDF 2007) having as a goal a 15% reduction among the assessment performed in the week before the beginning of the interventions and on the week after the completion of 16 and 32 weeks of intervention.
© Copyright 2025. All Rights Reserved by MedPath